Promoter hypermethylation of multiple genes in primary gastric lymphoma

Leukemia and Lymphoma

Volumn 48, Issue 10, 2007, Pages 1988-1996

  Huang, Qin ^a   Su, Xiaobo ^b   Ai, Lingbao ^b   Li, Michelle ^b   Fan, Chun Yang ^b   Weiss, Lawrence M ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Extragastric involvement; Primary gastric lymphoma; Promoter hypermethylation

Indexed keywords

ATM PROTEIN; DEATH ASSOCIATED PROTEIN KINASE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MLH1; PROTEIN P16INK4A; UVOMORULIN;

ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER STAGING; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FOLLICULAR LYMPHOMA; GENE FREQUENCY; GENE FUNCTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MALIGNANT TRANSFORMATION; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; PROMOTER REGION; STOMACH LYMPHOMA; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; DNA DAMAGE; DNA METHYLATION; DNA REPAIR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); STOMACH NEOPLASMS;

EID: 35148830823     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701573224     Document Type: Article

References (30)

1. Esteller, M., Corn, P. G., Baylin, S. B. and Herman, J. G. (2001) A gene hypermethylation profile of human cancer. Cancer Res, 61, pp. 3225-3229.
2. Herman, J. G. and Baylin, S. B. (2000) Promoter region hypermethylation and gene silencing in human cancer. DNA Methylation and Cancer, pp. 35-50. Springer-Verlag, New York
3. Robertson, K. D. and Jones, P. A. (2000) DNA methylation: Past, present and future directions. Carcinogenesis, 21, pp. 461-467.
4. Esteller, M. (2003) Relevance of DNA methylation in the management of cancer. Lancet Oncl, 4, pp. 351-358.
5. Harris, N. L. (2001) Mature B-cell neoplasms. Pathology and Genetics: Tumor of Haematopoietic and Lymphoid Tissues, pp. 121-126. IARC Press, Lyon
6. Dolan, M. E. and Schilsky, R. L. (2002) Silence is golden: Gene hypermethylation and survival in large cell lymphoma. J Natl Cancer Inst, 94, pp. 6-7.
7. KIP2 are involved in the development and progression of gastric MALT lymphomas. Mod Pathol, 19, pp. 141-148.
8. Go, J. H. (2003) Methylation analysis of cyclin-dependent kinase inhibitor genes in primary gastrointestinal lymphomas. Mod Pathol, 16, pp. 752-755.
9. Takahashi, T., Shivapurkar, N., Reddy, J., Shigematsu, H., Miyajima, K. and Suzuki, M. (2004) DNA methylation profiles of lymphoid and hematopoietic malignancies. Clin Cancer Res, 10, pp. 2928-2935.
10. 6 -methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. J Natl Cancer Inst, 94, pp. 26-32.
11. Corn, P. G., Kuerbitz, S. J., van Noesel, M. M., Esteller, M., Compitello, N. and Baylin, S. B. (1999) Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation. Cancer Res, 59, pp. 3352-3356.
12. Du, M. Q. and Isaccson, P. G. (2002) Gastric MALT lymphoma: From aetiology to treatment. Lancet Oncol, 3, pp. 97-104.
13. Willis, T. G., Jadayel, D. M., Du, M. Q., Peng, H., Perry, A. R. and Abdul-Rauf, M. (1999) Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell, 96, pp. 35-45.
14. Liu, H., Dogan, A., Ranaldi, R., Hamoudi, R. A. and Bearzi, I. (2001) t(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood, 98, pp. 1182-1187.
15. Streubel, B., Lamprecht, A., Dierlamm, J., Cerroni, L., Stolte, M. and Ott, G. (2003) t(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood, 101, pp. 2335-2339.
16. Sagaert, X., De Wolf-Peeters, C., Noels, H. and Baens, M. The pathogenesis of MALT lymphomas: Where do we stand?. Leukemia
17. Vo, Q. N., Zuo, C., Ling, W. and Suen, J. Y. (2004) Ataxia-telangiectasia-mutated (ATM) gene in head and neck squamous cell carcinoma: Promoter hypermethylation with clinical correlation in 100 cases. Cancer Epidem Biomarkers & Prev, 13, pp. 150-156.
18. Viswanathan, M., Tsuchida, N. and Shanmugam, G. (2003) Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int J Cancer, 105, pp. 41-46.
19. Fan, C. Y. (2004) Epigenetic alterations in head and neck cancer: prevalence, clinical significance, and implications [Review]. Curr Oncol Rep, 6, pp. 152-161.
20. Stephenson, K. K., Ling, W., Chunlai, Z., Mukunyadzi, P. and Suen, J. Y. (2003) The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: A promoter methylation and protein expression study in 100 cases. Mod Pathol, 16, pp. 944-950.
21. Huang, Q., Zhang, Z. Y., Fan, C. Y. and Weiss, L. M. (2004) Promoter hypermethylation and protein expression of the p16 gene: Analysis of 43 cases of B-cell primary gastric lymphomas from China. Mod Pathol, 17, pp. 416-422.
22. Shiozawa, E., Takimoto, M., Makino, R., Adachi, D., Saito, B. and Yamochi-Onizuka, T. (2006) Hypermethylation of CpG islands in p16 as a prognostic factor for diffuse large B-cell lymphoma in a high-risk group. Leuk Res, 30, pp. 859-867.
23. Nakatsuka, S., Takakuwa, T., Tomita, Y., Hoshida, Y., Nishiu, M. and Yamaguchi, M. (2003) Hypermethylation of death-associated protein (DAP) kinase CpG island is frequent not only in B cell but also in T- and natural killer (NK)/T-cell malignancies. Cancer Sci, 94, pp. 87-91.
24. Nakatsuka, S., Takakuwa, T., Tomita, Y., Hideaki, M., Matsuzuka, F. and Aozasa, K. (2000) Role of hypermethylation of DAP-kinase CpG island in the development of thyroid lymphoma. Lab Invest, 80, pp. 1651-1655.
25. Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F. and Vanaclocha, V. (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med, 343, pp. 1350-1354.
26. Tang, X., Khuri, F. R., Lee, J. J., Kemp, B. L., Liu, D. and Hong, W. K. (2000) Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. J Natl Cancer Inst, 92, pp. 1511-1516.
27. Shiramizu, B. and Mick, P. (2003) Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma. Med Pediatr Oncol, 41, pp. 527-531.
28. 6-methylguanine-DNA methyltransferase gene: Epigenetic silencing and prognostic value in head and neck squamous cell carcinoma. Cancer Epidem Biomarkers & Prev, 13, pp. 967-975.
29. 6-methylguanine-DNA methyltransferase protein expression is a favorable prognostic marker in diffuse large B-cell lymphoma. Int J Hematol, 83, pp. 341-347.
30. Kaneko, Y., Sakurai, S., Hironaka, M., Sato, S., Oguni, S. and Sakuma, Y. (2003) Distinct methylated profiles in Helicobacter pylori dependent and independent gastric MALT lymphomas. Gut, 52, pp. 641-646.